Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento

Jessica L. Pinto; Gloria E. Mora; Daniel G. Fernández-Avila; Juan M. Gutiérrez; María C. Díaz

doi:10.1016/j.reuma.2012.06.009

Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento

Jessica L. Pinto, Gloria E. Mora, Daniel G. Fernández-Avila, Juan M. Gutiérrez, María C. Díaz

Hospital Universitario San Ignacio

Producción: Contribución a una revista › Artículo › revisión exhaustiva

8 Citas (Scopus)

Resumen

Gout is a disease characterized by acute episodes of pain, which occurs as the result of monosodic urate crystal deposit in the joint and periarticular tissue. In some cases, gout behaves as a severe inflammatory arthopathy that is difficult to manage, generating structural joint damage and functional impairment. We report the case of a 44 years old man with gouty arthritis for 12 years, not responding to NSAIDs, alopurinol, colchicine or corticosteroids. Tocilizumab was started with favorable clinical and laboratory results after treatment.

Título traducido de la contribución	Tocilizumab in a patient with tophaceous gout resistant to treatment
Idioma original	Estonio
Páginas (desde-hasta)	178-180
Número de páginas	3
Publicación	Reumatologia Clinica
Volumen	9
N.º	3
DOI	https://doi.org/10.1016/j.reuma.2012.06.009
Estado	Publicada - may. 2013
Publicado de forma externa	Sí

Acceder al documento

10.1016/j.reuma.2012.06.009

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{1b9d818c412f499bb1c020a13d31f856,

title = "Tocilizumab en paciente con gota tof{\'a}cea severa refractaria al tratamiento",

abstract = "Gout is a disease characterized by acute episodes of pain, which occurs as the result of monosodic urate crystal deposit in the joint and periarticular tissue. In some cases, gout behaves as a severe inflammatory arthopathy that is difficult to manage, generating structural joint damage and functional impairment. We report the case of a 44 years old man with gouty arthritis for 12 years, not responding to NSAIDs, alopurinol, colchicine or corticosteroids. Tocilizumab was started with favorable clinical and laboratory results after treatment.",

keywords = "Rheumatoid arthritis, Severe tophaceous gout, Tocilizumab",

author = "Pinto, {Jessica L.} and Mora, {Gloria E.} and Fern{\'a}ndez-Avila, {Daniel G.} and Guti{\'e}rrez, {Juan M.} and D{\'i}az, {Mar{\'i}a C.}",

year = "2013",

month = may,

doi = "10.1016/j.reuma.2012.06.009",

language = "Estonio",

volume = "9",

pages = "178--180",

journal = "Reumatologia Clinica",

issn = "1699-258X",

publisher = "Ediciones Doyma, S.L.",

number = "3",

}

TY - JOUR

T1 - Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento

AU - Pinto, Jessica L.

AU - Mora, Gloria E.

AU - Fernández-Avila, Daniel G.

AU - Gutiérrez, Juan M.

AU - Díaz, María C.

PY - 2013/5

Y1 - 2013/5

N2 - Gout is a disease characterized by acute episodes of pain, which occurs as the result of monosodic urate crystal deposit in the joint and periarticular tissue. In some cases, gout behaves as a severe inflammatory arthopathy that is difficult to manage, generating structural joint damage and functional impairment. We report the case of a 44 years old man with gouty arthritis for 12 years, not responding to NSAIDs, alopurinol, colchicine or corticosteroids. Tocilizumab was started with favorable clinical and laboratory results after treatment.

AB - Gout is a disease characterized by acute episodes of pain, which occurs as the result of monosodic urate crystal deposit in the joint and periarticular tissue. In some cases, gout behaves as a severe inflammatory arthopathy that is difficult to manage, generating structural joint damage and functional impairment. We report the case of a 44 years old man with gouty arthritis for 12 years, not responding to NSAIDs, alopurinol, colchicine or corticosteroids. Tocilizumab was started with favorable clinical and laboratory results after treatment.

KW - Rheumatoid arthritis

KW - Severe tophaceous gout

KW - Tocilizumab

UR - http://www.scopus.com/inward/record.url?scp=84877106559&partnerID=8YFLogxK

U2 - 10.1016/j.reuma.2012.06.009

DO - 10.1016/j.reuma.2012.06.009

M3 - Artículo

C2 - 23122521

AN - SCOPUS:84877106559

SN - 1699-258X

VL - 9

SP - 178

EP - 180

JO - Reumatologia Clinica

JF - Reumatologia Clinica

IS - 3

ER -

Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto